Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03930732 |
|---|---|
| Brief Title: | Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 Inflammation (BOREAS) |
| First Submitted : | April 26, 2019 |
| First Submitted that Met QC Criteria : | April 26, 2019 |
| First Posted : | April 29, 2019 |
| Results First Submitted : | January 30, 2024 |
| Results First Submitted that Met QC Criteria : | January 30, 2024 |
| Results First Posted : | February 28, 2024 |
| Last Update Submitted that Met QC Criteria : | January 30, 2024 |
| Last Update Posted : | February 28, 2024 |